Acadia Pharmaceuticals Inc (ACAD)

Acadia Pharmaceuticals Inc Azioni (ACAD) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	11.15%342.29	307.96	268.06	283.99	278.63
Cost Of Revenue	23.92%35.09	28.32	24.79	26.23	21.65
	0.66%159.20	160.25	171.02	-	-
Selling, General, and Administrative	0.66%159.20	160.25	171.02	-	-
Research and Development	6.47%76.28	81.56	76.87	-	-
Costs And Expenses	0.17%270.57	270.12	272.68	266.60	242.88
Operating Income/Loss	89.55%71.72	37.84	-4.62	17.39	35.76
Income/Loss From Continuing Operations Before Tax	73.09%80.44	46.47	3.98	26.32	44.60
Income Tax Expense/Benefit	79.76%26.92	14.97	0.34	-247.25	-27.18
	69.92%53.52	31.50	3.64	273.57	71.78
Attributable To Parent	69.92%53.52	31.50	3.64	273.57	71.78
Available To Common Stockholders, Basic	69.92%53.52	31.50	3.64	273.57	71.78
Basic Average Shares	0.55%172.55	171.60	170.52	0.52	168.84
Diluted Average Shares	1.51%175.47	172.85	172.71	0.76	170.65
Basic Earnings Per Share	72.22%0.31	0.18	0.02	1.62	0.43
Diluted Earnings Per Share	72.22%0.31	0.18	0.02	1.61	0.42